XXII International Conference on Bioencapsulation
September 17-19, 2014 - Bratislava, Slovakia
| Abstract : | [1 to 20] | [21 to 40] | [41 to 60] | [61 to 80] | [81 to 83] |
| Ref. | Contributions 1 to 20 (Ox.x : Orals; Pxx : Posters) | |
|---|---|---|
| O1-1 | Autoassembled nanoparticles of lecithin/chitosan for oral deliveryof the antica Colombo G, Sonvico F, Como C, Colombo P, Zani F, Buttini F, Bettini R, Rossi A, |
|
| O1-2 | Antileishmania activity using phospho-l- serine coated gelatin nanoparticles Khatik R, Dwivedi P, and Dwivedi A K *. |
|
| O1-3 | Sustained release of OP and gemcitabine from an implantable PLGA cylinder Allison S, Ellis J., Abdulkhalek S, Lappan C, Hrynyk M, Szewczuk M, Neufeld RJ |
|
| O1-4 | Microfluidic-conceived drug-loaded microcarriers Vandamme T., Khan I.U., Serra C.A., Anton N. |
|
| O1-5 | Novel diagnostic enzyme-responsive beads for detection of wound infection Ten Cate A.T., Heinzle A., Schiffer D., Sigl E., Binder B., et al |
|
| O1-6 | Stability and consumer acceptance of spray-dried betanin in model juices Kaimainen, M., Järvenpää, E., Laaksonen, O., Sandell, M. and Huopalahti, R. |
|
| O1-7 | Oral lipid based delivery system of arteether: an effective malaria chemotherapy Dwivedi P, Khatik R, Dwivedi A K and Mishra P R. |
|
| O1-8 | Encapsulation efficiency of hydrophobic components in pH responsive polymer mice Georgiadou, S., Koutroumanis, K. |
|
| O2-1 | Skeletal muscle as a potential transplantation site of microencapsulated islets Bochenek M. Qi M. Marchese E. Davis M. Wang Y. Lacik I. Strand B. Oberholzer J.* |
|
| O2-2 | Clinically relevant immunosuppression for encapsulated pig islet xenografts Safley S.A., Barber G.F., Duncanson S., Holdcraft R.W., Gazda L.S.,et al. |
|
| O2-3 | Cell Encapsulation for Controlled Delivery of Biological Therapies Orive G |
|
| O2-4 | Effect of immunomodulation on pericapsular fibrosis of alginate capsules in NHP Oberholzer J. Bochenek M. Qi M. Marchese E. McGarrigle J. Wang Y. Danielson K. L |
|
| O2-5 | Emulsion-based islet encapsulation: predicting and overcoming islet hypoxia. Fernandez SA, Bégin-Drolet A, Ruel J, Leask R, Piret JM and Hoesli CA |
|
| O2-6 | The role of DAMPs in immune response against encapsulated human islets Paredes-Juarez, G.A., Tjoelker, R.S., de Haan, B.J. and de Vos, P.* |
|
| O2-7 | Identifying the total number of therapeutically functional cells within capsules Santos E., Hernández R.M., Pedraz J.L., Orive G. |
|
| O2-8 | Encapsulation of lipophilic antitumor drug in polysaccharide microcontainers R. Akasov, T. Borodina, E. Zaitceva, E. Markvicheva |
|
| O3-1 | Synthetic Polycations for Calcium Alginate Capsules:Structure & Biocompatibility Kleinberger R.M., Burke N.A.D and *Stöver H.D.H. |
|
| O3-2 | Chemical Modifications of Alginate for Drug Delivery Kapishon V, Cunningham M, Neufeld R, Whitney R and Champagne P. |
|
| O3-3 | Photo-sensitive microcapsules based on azobenzene compounds Tylkowski B., Giamberini M., Fernandez Prieto S., Underiner T., Smets J. |
|
| O3-4 | Poly(Vinyl Alcohol) microspheres for drug delivery. Morelli.S., Holdich R.G. , Dragosavac M.M. |
|